Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tommaso Tabaglio

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Nucleic Acid Therapeutics|February 10, 2021
Splice-Switching Antisense Oligonucleotides as a Targeted Intrinsic Engineering Tool for Generating Armored Redirected T CellsErica Ceccarello, Tommaso Tabaglio, Sarene Koh, et al.
Chemical Communications (Cambridge, England)|September 23, 2024
A splice-switch oligonucleotide loaded self-cleavable DNA nanogelYuwei Hu, Feng Chen, Hongfang Lu, et al.
Science Signaling|April 4, 2019
Proteomics profiling of arginine methylation defines PRMT5 substrate specificityDaniele Musiani, Jabez Bok, Enrico Massignani, et al.
Journal of Cell Science|September 22, 2025
Differential splice isoforms of mouse CDK2 play functionally redundant roles during mitotic and meiotic divisionNathan Palmer, Nisan Ece Kalem-Yapar, Hanna Hultén, et al.
Life Science Alliance|November 21, 2018
MBNL1 alternative splicing isoforms play opposing roles in cancerTommaso Tabaglio, Diana Hp Low, Winnie Koon Lay Teo, et al.
Molecular Therapy. Nucleic Acids|February 10, 2025
Unveiling sequence-agnostic mixed-chemical modification patterns for splice-switching oligonucleotides using the NATURA platformTommaso Tabaglio, Taniya Agarwal, Wei Yuan Cher, et al.
Human Molecular Genetics|August 1, 2014
Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosisElvezia M Paraboschi, Valeria Rimoldi, Giulia Soldà, et al.
Cancer Cell|January 15, 2020
Epigenetic Silencing of CDR1as Drives IGF2BP3-Mediated Melanoma Invasion and MetastasisDouglas Hanniford, Alejandro Ulloa-Morales, Alcida Karz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2025
BLOC1S1 depletion via splice-switching oligonucleotides improves mitochondrial respiration and rescues ALS phenotypesJin-Hui Hor, Jin Rong Ow, Winanto Ng, et al.
Nature Communications|February 2, 2023
G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinomaMaxine S Y Lam, Jose Antonio Reales-Calderon, Jin Rong Ow, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Nucleic Acid Therapeutics|February 10, 2021
Splice-Switching Antisense Oligonucleotides as a Targeted Intrinsic Engineering Tool for Generating Armored Redirected T CellsErica Ceccarello, Tommaso Tabaglio, Sarene Koh, et al.
Chemical Communications (Cambridge, England)|September 23, 2024
A splice-switch oligonucleotide loaded self-cleavable DNA nanogelYuwei Hu, Feng Chen, Hongfang Lu, et al.
Science Signaling|April 4, 2019
Proteomics profiling of arginine methylation defines PRMT5 substrate specificityDaniele Musiani, Jabez Bok, Enrico Massignani, et al.
Journal of Cell Science|September 22, 2025
Differential splice isoforms of mouse CDK2 play functionally redundant roles during mitotic and meiotic divisionNathan Palmer, Nisan Ece Kalem-Yapar, Hanna Hultén, et al.
Life Science Alliance|November 21, 2018
MBNL1 alternative splicing isoforms play opposing roles in cancerTommaso Tabaglio, Diana Hp Low, Winnie Koon Lay Teo, et al.
Molecular Therapy. Nucleic Acids|February 10, 2025
Unveiling sequence-agnostic mixed-chemical modification patterns for splice-switching oligonucleotides using the NATURA platformTommaso Tabaglio, Taniya Agarwal, Wei Yuan Cher, et al.
Human Molecular Genetics|August 1, 2014
Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosisElvezia M Paraboschi, Valeria Rimoldi, Giulia Soldà, et al.
Cancer Cell|January 15, 2020
Epigenetic Silencing of CDR1as Drives IGF2BP3-Mediated Melanoma Invasion and MetastasisDouglas Hanniford, Alejandro Ulloa-Morales, Alcida Karz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2025
BLOC1S1 depletion via splice-switching oligonucleotides improves mitochondrial respiration and rescues ALS phenotypesJin-Hui Hor, Jin Rong Ow, Winanto Ng, et al.
Nature Communications|February 2, 2023
G9a/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinomaMaxine S Y Lam, Jose Antonio Reales-Calderon, Jin Rong Ow, et al.
Pageof 2